Work

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva

Year: 2020

Type: article

Study design: Case Report

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2020-001771

Authors: Michele Bartoletti, Roberta Mazzeo, Marco De Scordilli, Anna Del Fabro, Maria Grazia Vitale, Lucia Bortot, Milena Sabrina Nicoloso, Serena Corsetti, Marta Bonotto, Simona Scalone, Giorgio Giorda, Roberto Sorio, Claudia Andreetta, Maria Luisa Meacci, Rocco De Vivo, Gianpiero Fasola, Francesco Sopracordevole, Fabio Puglisi

Institutions: University of Udine, Centro di Riferimento Oncologico, Azienda sanitaria universitaria Friuli Centrale, Azienda Ospedaliera di Perugia, Ospedale San Bortolo, Azienda ULSS 8 Berica

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Eisai, Ipsen

OpenAlex ID: W3089969445

FWCI: 1.506

Cites: 15

Cited by: 35

Related to: 10